wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47324655-359F529A-996E-43B1-8059-85E27953F801
Q47324655-359F529A-996E-43B1-8059-85E27953F801
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47324655-359F529A-996E-43B1-8059-85E27953F801
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.
P2860
Q47324655-359F529A-996E-43B1-8059-85E27953F801
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47324655-359F529A-996E-43B1-8059-85E27953F801
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc0eb120f6f343180212783335a37d315556fb6e
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies